"Nuclear Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
| Descriptor ID |
D009687
|
| MeSH Number(s) |
D12.776.660
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nuclear Proteins".
Below are MeSH descriptors whose meaning is more specific than "Nuclear Proteins".
This graph shows the total number of publications written about "Nuclear Proteins" by people in this website by year, and whether "Nuclear Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 12 | 6 | 18 |
| 1996 | 15 | 3 | 18 |
| 1997 | 20 | 11 | 31 |
| 1998 | 18 | 10 | 28 |
| 1999 | 19 | 9 | 28 |
| 2000 | 26 | 12 | 38 |
| 2001 | 22 | 13 | 35 |
| 2002 | 24 | 9 | 33 |
| 2003 | 19 | 18 | 37 |
| 2004 | 26 | 20 | 46 |
| 2005 | 17 | 23 | 40 |
| 2006 | 14 | 9 | 23 |
| 2007 | 20 | 12 | 32 |
| 2008 | 16 | 15 | 31 |
| 2009 | 17 | 13 | 30 |
| 2010 | 17 | 6 | 23 |
| 2011 | 21 | 10 | 31 |
| 2012 | 16 | 14 | 30 |
| 2013 | 23 | 10 | 33 |
| 2014 | 15 | 23 | 38 |
| 2015 | 24 | 8 | 32 |
| 2016 | 18 | 16 | 34 |
| 2017 | 22 | 14 | 36 |
| 2018 | 20 | 15 | 35 |
| 2019 | 9 | 9 | 18 |
| 2020 | 14 | 12 | 26 |
| 2021 | 11 | 4 | 15 |
| 2022 | 4 | 9 | 13 |
| 2023 | 4 | 9 | 13 |
| 2024 | 4 | 8 | 12 |
| 2025 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nuclear Proteins" by people in Profiles.
-
Synthesis, Structure-Activity Relationships, and Antitumor Activities of Quinoxiline-Containing Inhibitors of the Protein-Protein Interactions between Transcription Coactivator AF9/ENL and DOT1L/AF4. J Med Chem. 2025 Sep 25; 68(18):19396-19414.
-
The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes. Arch Pathol Lab Med. 2025 Aug 01; 149(8):717-726.
-
?-catenin functions as a molecular adapter for disordered cBAF interactions. Mol Cell. 2025 Aug 21; 85(16):3041-3056.e9.
-
Recurrent de novo variants in the spliceosomal factor CRNKL1 are associated with severe microcephaly and pontocerebellar hypoplasia with seizures. Am J Hum Genet. 2025 Jul 03; 112(7):1722-1732.
-
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations. Blood Cancer J. 2025 03 15; 15(1):40.
-
ATRX silences Cartpt expression in osteoblastic cells during skeletal development. J Clin Invest. 2025 Jan 02; 135(1).
-
Sestrin2 balances mitophagy and apoptosis through the PINK1-Parkin pathway to attenuate severe acute pancreatitis. Cell Signal. 2025 Feb; 126:111518.
-
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929. J Thorac Oncol. 2025 Mar; 20(3):383-394.
-
Association of common and rare variants with Alzheimer's disease in more than 13,000 diverse individuals with whole-genome sequencing from the Alzheimer's Disease Sequencing Project. Alzheimers Dement. 2024 Dec; 20(12):8470-8483.
-
Molecular architecture and functional dynamics of the pre-incision complex in nucleotide excision repair. Nat Commun. 2024 10 01; 15(1):8511.